Research, Exploitation and Patenting in the Area of Human Embryonic Stem Cells 
in Europe – A Case of Concern Causing Inconsistency

Straus, Joseph

doi:10.1017/S1062798716000387

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Research, Exploitation and Patenting in the Area of Human Embryonic Stem Cells in Europe – A Case of Concern Causing Inconsistency

MPS-Authors

/persons/resource/persons51252

Straus, Joseph
MPI for Innovation and Competition, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Straus, J. (2017). Research, Exploitation and Patenting in the Area of Human Embryonic Stem Cells in Europe – A Case of Concern Causing Inconsistency. European review, 25(1), 107-120. doi:10.1017/S1062798716000387.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002C-2B77-4

Abstract

Research on human embryonic stem cells, their exploitation and patenting is a highly controversial issue. This contribution provides for some basic understanding of technologies involved. It discusses ethical issues and legal rules dealing with the research and exploitation of stem cells in Europe. Moreover, it presents and analyses in some detail the statutory provisions of the EU in dealing with the patenting of human embryonic stem cells and the interpretation and application of those rules by the Court of Justice of the European Union. Finally, the resulting inconsistencies of the system as applied are critically analysed and a suggestion how to resolve them offered.